This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
Alexion Pharmaceuticals(ALXN - Get Report) is a biopharmaceutical company engaged in the discovery, development and commercialization of therapeutic products aimed at treating patients with severe and life-threatening disease states, including those in the therapeutic areas of hematology, nephrology (including transplant rejection), neurology, ophthalmology and cancer. This stock is trading up 2.2% at $74 in recent trading after hitting a 52-week high of $74.44 earlier in the day.
Today's Range: $72.00-$74.44
52-Week Range: $40.04-$73.05
Three-Month Average Volume: 1.2 million
Alexion Pharmaceuticals has a market cap of $13.61 billion and an enterprise value of $12.96 billion. The stock trades at a trailing price-to-earnings of 91.22 and a forward price-to-earnings of 44.83. Its estimated growth rate for this year is 46.1%, and for next year it's pegged at 26.2%. The current short interest as a percentage of the float for Alexion Pharmaceuticals is very low at 1.5%.
From a technical standpoint, ALXN recently triggered a breakout trade when the stock took out some past overhead resistance at $70.50 to $72.50. This move today in the stock has pushed shares into all-time high territory, which is bullish for any stock.
Market players should continue to look for long biased trades as long as ALXN can continue to trend above $70.50 to $72.50.
Alexion is one of TheStreet Ratings'
top-rated biotechnology stocks.
To see more stocks hitting new 52-week highs today, check out the
Stocks Hitting New 52-Week Highs portfolio on Stockpickr.
-- Written by Roberto Pedone in Winderemere, Fla.